Report 88: 2.5 Months After COVID Vaccine Rollout, Pfizer Changed Criteria for ‘Vaccination Failure,’ Causing 99% of Reported Cases to Not Meet That Definition. 3.9% of Reported ‘Lack of Efficacy’ Cases Ended in Death in First 90 Days of Public Vaccine Availability.

The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – penned a telling analysis of the “Vaccine Effectiveness” Safety Concern section found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“).

It is important to note that the AESIs in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product.

Key highlights from this important report include:

• During the first three months of vaccine rollout, 1,665 cases were submitted to Pfizer with a definition of “lack of efficacy” (LOE).
  • There were 65 deaths (3.9%) among the lack of efficacy cases.
• Lack of efficacy cases fell into two categories:
  1. Drug ineffective
  2. Vaccination failure
• Without explanation, Pfizer revised the coding conventions (or criteria) for the “vaccination failure” category on February 15, 2021, two and a half months into the vaccine’s public rollout and a mere two weeks before data collection for the report ended.
  • The new definition of “vaccination failure” required all three of the following criteria to be met:
    • Both doses received per local regime.
    • At least seven days since the second dose.
    • Infection with confirmed lab test positive for SARS-CoV-2.
• Revising the criteria for vaccination failure likely allowed Pfizer to shift cases out of the “vaccination failure” category and into “drug ineffective” category. With the new definition, 1,649 cases, or 99%, of the 1,665 lack of efficacy cases met the “drug ineffective” criteria of:
  • Infection not confirmed by a lab test
  • Unknowns present:
    • Vaccine doses followed proper local regimen.
    • Number of days since first dose.
    • Whether seven days passed since second dose.
    • COVID onset between 14 days after first dose and through six days after second dose.
• However, based on data in 5.3.6, only 788 (47.8%) of the 1,649 drug ineffective cases can be stated categorically not to have been drug failure.
• 1,625 (98.5%) of the 1,649 “drug ineffective” cases were labeled as “serious.”
• Using the revised coding conventions, only 16 lack of efficacy cases, under 1%, were categorized as “vaccination failure.”
  • Up to another 861 cases may have been “vaccination failure” had missing data been collected.

Please read the full report below.

p1 Post Marketing Team Vaccine Effectiveness

https://dailyclout.io/wp-content/uploads/p1-Post-Marketing-Team-Vaccine-Effectiveness.pdf

p2 Post Marketing Vaccine Effectiveness

https://dailyclout.io/wp-content/uploads/p2-Post-Marketing-Vaccine-Effectiveness.pdf